Latest News

Keep up with the latest developments at IpiNovyx Bio. Here, you’ll find our official announcements, press releases, and news stories as we continue to advance our innovative therapies for autoimmune and inflammatory diseases.

News

Eli Lilly-backed IpiNovyx Bio emerges with $10M for 2023 clinical entry

Eli Lilly is among the investors backing preclinical biotech IpiNovyx Bio as it emerges with $10 million to go after inflammatory and autoimmune diseases.

Read more
News

IpiNovyx Bio has secured $10 million in seed financing to advance its groundbreaking immunoproteasome inhibitors toward clinical trials

Participating Investors include Viva BioInnovator, Eli Lilly and Company, Opaleye Management, Orange Grove Bio and Alexandria Venture Investments

Read more

Have Questions or Need More Information?

If you have any questions or would like more information about IpiNovyx Bio, feel free to reach out to us. We’re here to help.

Contact Us